Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
Announcements
Projects
Orgs
Project
Post
Articles 175
Votes 4
25% interested
nejm.org
Home
Members
Articles
Authors
1
nejm.org
«
Prev
…
3
4
5
6
7
Updated Health Warnings for Alcohol — Informing Consumers and Reducing Harm | NEJM - nejm.org
almost3y
Severe Subcutaneous Emphysema | NEJM - nejm.org
almost3y
Losing Contact — Covid-19, Telemedicine, and the Patient–Provider Relationship | NEJM - nejm.org
almost3y
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload | NEJM - nejm.org
almost3y
Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial | NEJM - nejm.org
almost3y
From Survival to Survivorship — Framing Traumatic Injury as a Chronic Condition | NEJM - nejm.org
almost3y
Removal of Small, Asymptomatic Kidney Stones and Incidence of Relapse | NEJM - nejm.org
almost3y
Bronchiectasis — A Clinical Review | NEJM - nejm.org
almost3y
Bringing Sickle-Cell Treatments to Children in Sub-Saharan Africa | NEJM - nejm.org
almost3y
Diagnostic Aspirations | NEJM - nejm.org
almost3y
Spina Bifida | NEJM - nejm.org
almost3y
Trial of Prasinezumab in Early-Stage Parkinson's Disease | NEJM - nejm.org
almost3y
Understanding REM Sleep Behavior Disorder in Parkinson's Disease | NEJM - nejm.org
almost3y
Oncogene Up-Regulation after Hypomethylating Therapy | NEJM - nejm.org
almost3y
Nonspecific Low Back Pain | NEJM - nejm.org
almost3y
Childhood Risk Factors and Adult Cardiovascular Events | NEJM - nejm.org
almost3y
Gliflozins in the Management of Cardiovascular Disease | NEJM - nejm.org
almost3y
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria | NEJM - nejm.org
almost3y
Monoclonal Antibody Therapy in Parkinson's Disease — The End? | NEJM - nejm.org
almost3y
Audio Interview: Updated Covid-19 Vaccines and a Look at Monkeypox | NEJM - nejm.org
almost3y
Trial of Cinpanemab in Early Parkinson's Disease | NEJM - nejm.org
almost3y
Tecovirimat and the Treatment of Monkeypox — Past, Present, and Future Considerations | NEJM - nejm.org
almost3y
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis | NEJM - nejm.org
~3y
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection | NEJM - nejm.org
>3y
Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents - nejm.org
~4y
«
Prev
…
3
4
5
6
7
Modal title
...
Profile
Loading profile
Loading...